share_log

8-K: Current report

SEC ·  Nov 14, 2024 06:11

Summary by Moomoo AI

BeiGene announced on November 14, 2024, its intention to change its company name to "BeOne Medicines Ltd." The rebranding initiative reflects the company's commitment to developing innovative cancer medicines through global partnerships to serve patients worldwide. The new name will be accompanied by a change in ticker symbol to "ONC" on the Nasdaq Global Select Market.The proposed name change is subject to shareholder approval at an upcoming shareholder meeting. The company plans to file a definitive proxy statement with the SEC containing detailed information about the name change and related matters for shareholder consideration.
BeiGene announced on November 14, 2024, its intention to change its company name to "BeOne Medicines Ltd." The rebranding initiative reflects the company's commitment to developing innovative cancer medicines through global partnerships to serve patients worldwide. The new name will be accompanied by a change in ticker symbol to "ONC" on the Nasdaq Global Select Market.The proposed name change is subject to shareholder approval at an upcoming shareholder meeting. The company plans to file a definitive proxy statement with the SEC containing detailed information about the name change and related matters for shareholder consideration.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more